Children who contracted COVID-19 are at increased risk of being diagnosed with Type 1 diabetes. Researchers found a 72% increase in new Type 1 diabetes cases in those under 18 who contracted COVID-19.
Better glucose control can improve brain structure and function in young people with Type 1 diabetes.
Type 1 diabetes in either parent was associated with an increased risk of cognitive development problems and lower academic performance in children.
Neurons in the infralimbic cortex control the link between food cues and behavioral actions, such as overeating or bad food choices. When these neurons are regulated, the rat models consumed fewer treats.
Verbal IQ, overall IQ, and brain volume are lower in children with type 1 diabetes than in their peers without the disorder. Researchers believe the cognitive and brain development differences are associated with hyperglycemia.
Children with type 1 diabetes have slower growth of total cortical and subcortical gray and white matter compared to their peers without diabetes.
Researchers have developed small molecules that inhibit one of the main enzymes implicated in autoimmune response. The research could lead to potential new medications for a range of autoimmune diseases.
Researchers consider why those with autoimmune diseases are more likely to have a previous diagnosis of stress-related disorders.
A new method for studying the mircobiome has allowed researchers to identify a connection between metabolism in gut bacteria and the development of diabetes.
Using new technology to turn inflammation on and off in mice, researchers discover inflammation may contribute to sleep disorders.
Researchers report they have found no increased risk of autoimmune diseases in girls who received the HPV4 vaccine. The study adds to a growing body of evidence for the safety of the vaccine.
A mouse study reveals nerve cells damaged as a result of diabetes may not be repairable due to low levels of specific cytokines.
